Role of Epistatic (Modifier) Genes in the Modulation of the Phenotypic Diversity of Sickle Cell Anemia

References

• Ferrone F, Nagel R L. Polymer structure and polymerization of deoxyhemoglobin. Disorders of Hemoglobin: Genetics, Pathophysiology, Clinical Management, M HS Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press, Boston 2001
   Google Scholar
• Nagel R L. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia. Seminars in Hematology, K M Sullivan. W.B. Saunders, Philadelphia 1991; vol. 28: 180–201
   Google Scholar
• Nagel R L, Platt O. Pathophysiology of sickle cell anemia. Seminars in Hematology, K M Sullivan. W.B. Saunders, Philadelphia 1991; vol. 28: 180–201
   Google Scholar
• Noguchi C T, Rodgers G P, Serjeant G, Schechter A N. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 1988; 318: 96–99
   PubMed Web of Science ®Google Scholar
• Powars D, Weiss J N, Chan L S, Schroeder W A. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?. Blood 1984; 63: 921–926
   PubMed Web of Science ®Google Scholar
• Platt O S, Brambilla D J, Rosse W F, Milner P F, Castro O, Steinberg M H, Klug P P. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–1644
   PubMed Web of Science ®Google Scholar
• Stamatoyannopoulos G. Molecular and cellular basis of hemoglobin switching. Disorders of Hemoglobin: Genetics, Pathophysiology, Clinical Management, M H Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press, Boston 2001
   Google Scholar
• Nagel R L, Steinberg M H. Genetics of the ßs -gene: origins, genetic epidemiology, and epistasis in sickle cell anemia. Disorders of Hemoglobin: Genetics, Pathophysiology, Clinical Management, M H Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press. 2001
   Google Scholar
• Gilman J G, Huisman T HJ. DNA sequence variation associated with elevated fetal G globin production. Blood 1985; 66: 783–787
   PubMed Web of Science ®Google Scholar
• Nagel R L, Fabry M E, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 1984; 312: 880–884
   Web of Science ®Google Scholar
• Labie D, Srinivas R, Dunda O, Dode C, Lapoumeroulie C, Devi V, Devi S, Ramasami K, Elion J, Ducrocq R, et al. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. Hum Biol 1989; 61: 479–491
   PubMed Web of Science ®Google Scholar
• Steinberg M H, Hsu H, Nagel R L, Milner P F, Adams J G, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O, Hellman-Erlingsson S, Safaya S, Huey L, Rieder R F. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. American J Hematol 1995; 48: 175–181
   PubMed Web of Science ®Google Scholar
• Powars D R. Sickle cell anemia: ßs-Gene-cluster haplotypes as prognostic indicators of vital organ failure. Sem Hematol 1991; 28: 202–208
   PubMed Web of Science ®Google Scholar
• Powars D R. ßs -Gene-cluster haplotypes in sickle cell anemia: clinical and hematologic features. Hematol/Oncol Clinics N Am 1991; 5: 475–493
   PubMed Web of Science ®Google Scholar
• Powars D R, Elliott Mills D D, Chan L. Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 1991; 115: 614–620
   PubMed Web of Science ®Google Scholar
• Adekile A D, Dimovski A J, Oner C, Lanclos K D, Huisman T HJ. Haplotype-specific sequence variations in the locus control region (5′ hypersensitive sites 2, 3, 4) of ßs-chromosomes. Hemoglobin 1993; 17: 475–478
   PubMed Web of Science ®Google Scholar
• Mukherjee M B, Lu C Y, Ducrocq R, Gangakhedkar R R, Colah R B, Kadam M D, Mohanty D, Nagel R L, Krishnamoorthy R. Effect of α-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India. Am J Hematol 1997; 55: 104–109
   PubMed Web of Science ®Google Scholar
• Miller B A, Salameh M, Ahmed M, Olivieri N, Huisman T H, Orkin S H, Nathan D G. Saudi Arabian sickle cell anemia. A molecular approach. Ann NY Acad Sci 1989; 565: 143–151
   PubMed Web of Science ®Google Scholar
• Labie D, Srinivas R, Dunda O, Dode C, Lapoumeroulie C, Devi V, Devi S, Ramasami K, Elion J, Ducrocq R, et al. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the ßs mutation and the unicentric origin of the tribal populations of India. Hum Biol 1989; 61: 479–491
   PubMed Web of Science ®Google Scholar
• Ofori-Acquah S F, Lalloz M RA, Layton D M. Localization of cis regulatory elements at the ß-globin locus: analysis of hybrid haplotype chromosomes. Biochem Biophys Res Comm 1999; 254: 181–187
   PubMed Web of Science ®Google Scholar
• Dover G J, Boyer S H, Charache S, Heintzelman K. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 1978; 299: 1428–1435
   PubMed Web of Science ®Google Scholar
• Garner C, Tatu T, Reittie J E, Littlewood T, Darley J, Cervino S, Farrall M, Kelly P, Spector T D, Thein S L. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000; 95: 342–6
   PubMed Web of Science ®Google Scholar
• Game L, Close J, Stephens P, Mitchell J, Best S, Rochette J, Louis-dit-Sully C, Riley J, See C G, Sanseau P, Kearney L, Bethel G, Humphray S, Dunham I, Mungall A, Thein S L. An integrated map of human 6q22.3-q24 including a 3-Mb high-resolution BAC/PAC contig encompassing a QTL for fetal hemoglobin. Genomics 2000; 64: 264–276
   PubMed Web of Science ®Google Scholar
• Tang W, Smith K, Dover G. The F-cell production locus is mapped between DXS 452 and APXL, and interval of 2–3 cM on Xp22.2 (abstract). The 12th Conference on Hemoglobin Switching. 2000
   Google Scholar
• Billett H H, Nagel R L, Fabry M E. Paradoxical increase of painful crises in sickle cell patients with α-thalassemia. Blood 1995; 86: 4382–4382
   PubMed Web of Science ®Google Scholar
• Adekile A D, Tuli M, Haider M Z, Al-Zaabi K, Mohannadi S, Owunwanne A. Influence of α-thalassemia trait on spleen function in sickle cell anemia patients with high HbF. Am J Hematol 1996; 53: 1–5
   PubMed Web of Science ®Google Scholar
• Steinberg M H. Compound heterozygous and other sickle hemoglobinopathies. Disorders of Hemoglobin: Genetics, Pathophysiology, Clinical Management, M H Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press, Cambridge, UK 2001
   Google Scholar
• Mears J G, Lachman H M, Labie D, Nagel R L. Alpha thalassemia is related to prolonged survival in sickle cell anemia. Blood 1983; 62: 286–290
   PubMed Web of Science ®Google Scholar
• Muniz A, Svarch E, Espinosa E, Nagel R L, Martinez G. Potential effect of changing levels of medical care on the age-dependency of the frequency of α-thalassemia in sickle cell anemia (personal communication)
   Google Scholar
• Rieder R F, Safaya S, Gillette P, Fryd S, Hsu H, Adams J G, III, Steinberg M H. Effect of α-globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia. Am J Hematol 1991; 36: 184–189
   PubMed Web of Science ®Google Scholar
• Steinberg M H, Embury S H. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 1986; 68: 985–990
   PubMed Web of Science ®Google Scholar
• Steinberg M H, Adams J G, III. Hemoglobin A2: origin, evolution, and aftermath. Blood 1991; 78: 2165–2177
   PubMed Web of Science ®Google Scholar
• Beutler E, Johnson C, Powars D, West C. Prevalence of glucose-6-phosphate dehydrogenase deficiency in sickle cell anemia. N Engl J Med 1974; 290: 826–828
   PubMed Web of Science ®Google Scholar
• Piomelli S, Reindorf C, Arzanian M T, Corash L M. Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficienct and sickle-cell anemia. N Engl J Med 1972; 287: 213–217
   Google Scholar
• Steinberg M H, Dreiling B J. Glucose-6-phosphate dehydrogenase deficiency in sickle-cell anemia. A study in adults. Ann Intern Med 1974; 80: 217–220
   Google Scholar
• Steinberg M H, West M S, Gallagher D, Mentzer W. Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia. Blood 1988; 71: 748–752
   PubMed Web of Science ®Google Scholar
• Bouanga J C, Mouélé R, Préhu C, Wajcman H, Feingold J, Galactéros F. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Heredity 1998; 48: 192–197
   PubMed Web of Science ®Google Scholar
• Francis Jr, Hebbel R P. Hemostasis. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Lippincott-Raven, New York 1994; 299–310
   Google Scholar
• Kutlar F, Tural C, Park D, Markowitz R B, Woods K F, Kutlar A. MTHFR (5, 10-methlylenetetrathydrofolate reductase) 677 C → T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood 1998; 92: 695a
   PubMed Web of Science ®Google Scholar
• Zimmerman S A, Ware R E. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 1998; 59: 267–272
   PubMed Web of Science ®Google Scholar
• Zimmerman S A, Howard T A, Whorton M R, Rosse W F, Ware R E. The A312G polymorphism in α-fibrinogen is associated with stroke and avascular necrosis in patients with sickle cell anemia. Blood 1998; 92: 36b
   Google Scholar
• Andrade F L, Annichino-Bizzacchi J M, Saad S TO, Costa F F, Arruda V R. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetra-hydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 1998; 59: 46–50
   PubMed Web of Science ®Google Scholar
• Nsiri B, Ghazouani E, Gritli N, Mazigh C, Bayoudh F, Messaoud T, Fattoum S, Machghoul S. Antiphospholipid antibodies: lupus anticoagulants anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease. Hematol Cell Ther 1998; 40: 107–112
   PubMedGoogle Scholar
• Driscoll M C, Hurlet A, Berman B, Files B, Styles L, Pegelow C, Olivieri N, McKie V, Patel K. Stroke risk in sibling pairs with sickle cell disease. Am J Hum Gen 1999; 65: A201
   Google Scholar
• Driscoll M C, Prauner R. 5′, 10′Methylenetetrahydrofolate reductase C677T mutant and ischemic stroke in sickle cell disease. Thromb Haemostasis 1999; 82: 1780
   PubMed Web of Science ®Google Scholar
• Tang D C, Prauner R, Liu W, Kim K, Hirsch R, Driscoll M C, Rodgers G P. The angiotensinogen GT dinucleotide repeat is associated with stroke in children with sickle cell anemia. National Sickle Cell Disease Center Meeting, Philadelphia, 1999
   Google Scholar